BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 28, 2008
View Archived Issues
New Target Raises Hopes for Future Cancer Vaccines
Read More
Amsterdam Molecular Signs CRADA for Gene Therapy
Read More
BioAlliance Buys Rights to NovaDel's Ondansetron
Read More
Myriad Gets $100M Up Front in European Deal for Flurizan
Read More
EU Biosimilar Debate Moves to Use in Clinical Practice
LONDON - With the first generic biologics reaching the market in Europe, the focus has shifted from arguments about how to approve them, to how the products should be used in clinical practice. (BioWorld International)
Read More
Daiichi Sankyo Paying $235M For U3's Oncology Pipeline
Read More
Other News To Note
Read More